Connect with us

Technology

NIIMBL announces 2 RFIs focused on data connectivity and federated learning for biopharmaceutical manufacturing

Published

on

NEWARK, Del., Aug. 5, 2024 /PRNewswire/ — The National Institute for Innovation in Manufacturing Biopharmaceuticals is pleased to announce two Requests for Information (RFI) related to universal connectivity and federated learning as part of the Institute’s Big Data Program. The Institute invites submissions from data science experts with knowledge of connectivity systems and federated learning.

Universal Connectivity for In-process Analytics in Biopharmaceutical Manufacturing (RFI 2024.1) seeks information on potential solutions for a universal connectivity system for at-line and/or inline analytical instrumentation. This system is envisioned as an OT/IT core to facilitate seamless data integration and advanced analytics within biomanufacturing processes, thus enabling data-driven decision making and process optimization. The submission deadline is August 30, 2024. Learn more about the Universal Connectivity RFI.

Hybrid Model Federated Learning (RFI 2024.2) requests information on innovative approaches that combine federated learning with hybrid models (combining Physics-Based and AI/ML data-driven methodologies) specifically tailored for biopharmaceutical manufacturing processes. This request aims to gather insights and concepts for achieving integration and operationalization of these models in a practical, industry-relevant context. The submission deadline is September 23, 2024. Learn more about the Hybrid Model Federated Learning RFI.

“Enhanced data integration and predictive modeling are essential to help biopharmaceutical manufacturers make data-driven, analytics-based decisions to optimize manufacturing processes. These two RFIs will help NIIMBL’s Big Data Program tackle these challenges for the industry,” said Roger Hart, NIIMBL Senior Fellow and Big Data Program Lead.

NIIMBL’s Big Data Program aims to accelerate the development and adoption of data-driven innovation and standards to increase the speed and resilience of biopharmaceutical manufacturing. The Program includes five workstreams focused on data creation, transformation, storage, prediction, and control.

These RFIs aim to collect information only and are not a solicitation for funding.

Click here to learn more about the Universal Connectivity RFI.

Click here to learn more about the Hybrid Model Federated Learning RFI.

To learn more about NIIMBL, including how to be a member, visit NIIMBL.org.

About NIIMBL

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is a public-private partnership whose mission is to accelerate biopharmaceutical innovation, support the development of standards that enable more efficient and rapid manufacturing capabilities, and educate and train a world-leading biopharmaceutical manufacturing workforce, fundamentally advancing U.S. competitiveness in this industry. NIIMBL is part of Manufacturing USA®, a diverse network of federally sponsored manufacturing innovation institutes, and is funded through a cooperative agreement with the National Institute of Standards and Technology (NIST) in the U.S. Department of Commerce with significant additional support from its members.

Contact
News Media
Daniel Maiese
Communications Manager
302-831-3824
dmaiese@udel.edu

View original content to download multimedia:https://www.prnewswire.com/news-releases/niimbl-announces-2-rfis-focused-on-data-connectivity-and-federated-learning-for-biopharmaceutical-manufacturing-302213674.html

SOURCE National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

iFOREX Lists on London Stock Exchange, Supporting Focus Across Global and Indian Markets

Published

on

By

LONDON, April 17, 2026 /PRNewswire/ — iFOREX today announced its recent admission to the Main Market of the London Stock Exchange (LSE) under the ticker IFRX, at a market valuation of approximately £43.3 million. This milestone marks a significant step in the Company’s long-term growth strategy and supports its continued expansion across international markets, including a growing focus on India.

With over 30 years of experience in the online trading industry, iFOREX has established a strong global presence built on proprietary technology, consistent innovation, and disciplined risk management. The Company continues to deliver advanced trading solutions alongside a high standard of client support, designed to meet the evolving needs of retail traders in dynamic markets.

Through its proprietary web-based and mobile trading platforms, iFOREX provides access to over 900 financial instruments, including foreign exchange, commodities, indices, stocks, cryptocurrencies, and ETFs. The Company continuously enhances its technology and product offering to deliver a seamless, secure, and efficient trading experience for its global client base.

India represents an increasingly important market for iFOREX, supported by a rapidly growing base of digitally engaged traders and rising interest in global financial markets. The Company aims to strengthen its presence by offering localized support, tailored educational resources, and technology-driven solutions aligned with the needs of Indian traders.

The Company’s admission to the London Stock Exchange enhances its visibility and credibility as a global fintech provider, focusing on investing in platform development, optimizing client experience, and scaling its international operations to support long-term growth.

“Our listing on the London Stock Exchange represents an important milestone in iFOREX’s evolution as a global trading provider,” said Itai Sadeh, Chief Executive Officer of iFOREX. “We see significant potential in the Indian market, driven by strong demand for digital trading solutions and increasing participation in global markets. We remain committed to expanding our presence in India while continuing to invest in technology, innovation, and client experience.”

iFOREX will continue to monitor market developments, adapt its offering to the needs of traders across different regions, and focus on delivering reliable services, transparent trading conditions, and long-term value to its clients and stakeholders.

Find out more here: iFOREX Website

This press release is intended solely for media use. It is not meant for individual investors and does not contain personal advice or recommendations.

 

View original content:https://www.prnewswire.com/in/news-releases/iforex-lists-on-london-stock-exchange-supporting-focus-across-global-and-indian-markets-302755696.html

Continue Reading

Technology

iFOREX Lists on London Stock Exchange, offering Cryptocurrency trading (CFDs) Across Global and LATAM Markets

Published

on

By

LONDON, April 29, 2026 /PRNewswire/ — iFOREX today announced its admission to the Main Market of the London Stock Exchange (LSE) under the ticker IFRX, with a market valuation of approximately £43.3 million. This milestone represents a major step in the Company’s global growth strategy and supports its continued expansion across international markets, including cryptocurrency CFD trading for retail investors in Latin America (LATAM) and beyond.

The listing underscores iFOREX’s commitment to combining traditional financial instruments with the evolving opportunities presented by the cryptocurrency market. Over the past decade, iFOREX has offered retail traders access to a broad portfolio of crypto CFDs, including Bitcoin (BTC), Ethereum (ETH), Ripple (XRP), Litecoin (LTC), and a growing range of other digital assets, alongside forex, commodities, indices, equities, and ETFs. The Company’s proprietary online and mobile platforms allow traders to seamlessly navigate both crypto and traditional markets from a single interface.

With more than 25 years of experience in online trading, iFOREX has built a solid global presence based on proprietary technology, disciplined risk management, and continuous innovation. By integrating crypto trading alongside traditional instruments, the Company provides traders with diversified opportunities, enhanced liquidity, and sophisticated tools to manage risk and capitalize on market trends.

Latin America represents a particularly high-growth region for cryptocurrency trading, supported by increasing digital adoption, rising interest in global financial markets, and a growing number of self-directed retail investors. iFOREX is committed to strengthening its presence in the region by offering localized services, multilingual support, and educational resources specifically designed to help LATAM clients engage confidently with both crypto and forex markets.

The LSE listing enhances iFOREX’s credibility and visibility as a global fintech provider while supporting its strategy to expand crypto trading offerings, scale operations, and provide long-term value to clients and shareholders. The Company continues to focus on platform innovation, regulatory compliance, and the development of tools that allow traders to execute informed and secure transactions across all available markets.

Itai Sadeh, Chief Executive Officer of iFOREX, commented:

“Our admission to the Main Market of the London Stock Exchange represents a landmark moment for iFOREX and reflects our commitment to innovation in financial trading, including cryptocurrencies. Latin America presents strong growth potential in digital assets, and we are focused on providing robust, reliable platforms, localized education, and tools that empower traders to access opportunities across both crypto and traditional markets.”

Looking forward, iFOREX plans to expand its crypto product offering, explore emerging digital asset trends, and continue delivering a secure, innovative, and client-focused trading experience to retail investors worldwide.

 

View original content:https://www.prnewswire.co.uk/news-releases/iforex-lists-on-london-stock-exchange-offering-cryptocurrency-trading-cfds-across-global-and-latam-markets-302755709.html

Continue Reading

Technology

Temu and QIMA Partner to Strengthen Product Testing and Platform Compliance

Published

on

By

DUBLIN, April 29, 2026 /PRNewswire/ — Temu, the global e-commerce platform, and QIMA, a leading testing, inspection, and certification company, today announced a partnership to strengthen product compliance and safety across the Temu platform. Under the partnership, QIMA’s testing and certification services will be integrated directly into Temu’s Seller Center, making compliance resources accessible to sellers.

QIMA will deliver independent product testing, on-site factory inspections, seller training programs, and digital compliance tools. Product testing will cover four initial categories: electrical and electronic goods, jewelry and gemstones, food contact materials, and light industrial products. Testing will be conducted against applicable regulatory and safety standards. QIMA will also conduct on-site factory inspections for selected sellers to verify production processes and supply chain practices at the source.

The Temu-QIMA partnership also includes structured training programs designed to help sellers better understand testing standards and regulatory requirements across markets, along with regular roundtables and workshops on evolving rules, policy developments, and compliance approaches.

“As e-commerce platforms serve more markets and more product categories, independent compliance infrastructure becomes essential, not optional,” said Pierre-Nicolas Disser, CEO of Consumer Products, QIMA. “This partnership, and particularly the integration into Temu’s Seller Center, is a step toward making compliance testing and certification a routine part of how sellers operate. That’s exactly the kind of work QIMA’s global network was built for.”

The partnership with QIMA builds on Temu’s broader product safety and compliance program. In 2025, the company invested approximately US$100 million globally in compliance, product safety, and quality control, with plans to double that investment in 2026. To date, Temu has established cooperation with more than 60 independent testing institutions worldwide. The partnership with QIMA represents one of the first integration of third-party compliance tools directly into the Temu Seller Center workflow.

“Temu prioritizes the safety of products on our platform, and our partnership with QIMA is a concrete step in that direction,” said a Temu spokesperson. “Together with QIMA, we are focused on providing consumers with a safe and trustworthy shopping experience, while making compliance resources more accessible to sellers on our platform.”

About Temu

Temu is a global e-commerce platform connecting consumers with millions of manufacturers, brands, and business partners. Operating in more than 90 markets worldwide, Temu is committed to providing affordable, high-quality products that enable customers to live better lives.

About QIMA

At QIMA, we are on a mission to help our clients make products consumers can trust. We have developed compliance solutions for testing, inspection and certification (TIC) that enable supply chain agility, sustainability, and product innovation. Our services are used by 30,000 businesses globally in the consumer products, agri-food and life sciences industries. What truly sets us apart is our unique culture of relentless care for our clients, and a commitment to offering intuitive solutions that blend deep tech and human intelligence; this is how QIMA continues to disrupt the Testing, Inspection and Certification industry.

SOURCE Temu

Continue Reading

Trending